US Patent Issued to Berkeley Therapeutics on Dec. 16 for "Antibody, antibody fragments or peptide for treating cancer and methods of formation and administration" (California Inventor)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,497,464, issued on Dec. 16, was assigned to Berkeley Therapeutics Inc. (Oakland, Calif.).

"Antibody, antibody fragments or peptide for treating cancer and methods of formation and administration" was invented by Paul William Wolski (Oakland, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Treatments for pathogens and diseases are disclosed. More specifically, various treatments disclosed include the use of antibodies that specifically target receptors within cells. The binding of the antibody to a receptor within the cell causes the death of the cell. Various treatments are directed to the targeting of cells associated with diseases such as cancer...